Bottom line
ETHSX vs DLHIX: the short answer
ETHSX (Eaton Vance Worldwide Health Sciences Fund) and DLHIX (Nomura Healthcare Fund) share a meaningful slice of their top holdings — about 42% by weight.
But DLHIX is far broader, holding 108 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
DLHIX is cheaper at 0.96% vs 1.18% — a difference of $22 a year per $10,000 invested.
Over five years, DLHIX returned +7.8% a year vs +5.3% for ETHSX (reporting dates differ).
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
ETHSX vs DLHIX side by side
| ETHSX | DLHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Morgan Stanley | Voya |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.18% | 0.96% |
| Annual cost per $10k | $118 | $96 |
| 10-yr cost on $10k (prospectus) | $1,911 | $1,232 |
| Max front load | 5.25% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −1.9% | +22.4% |
| 5-yr return (annualized) | +5.3% | +7.8% |
| 10-yr return (annualized) | +6.4% | +10.4% |
| Best quarter | +14.2% | — |
| Worst quarter | −12.1% | — |
| Net assets (fund) | $757.9M | $750.2M |
| Number of holdings | 42 | 108 |
| Portfolio turnover | 3% | 4% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of ETHSX's top 25 holdings also appear in DLHIX's top 25.
| Holding | ETHSX | DLHIX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 4.16% |
| AbbVie Inc | 6.46% | 4.19% |
| AstraZeneca PLC | 6.24% | 3.27% |
| UnitedHealth Group Inc | 5.49% | 3.88% |
| Roche Holding AG | 5.44% | 3.01% |
| Merck & Co Inc | 5.08% | 3.68% |
| Vertex Pharmaceuticals Inc | 3.38% | 1.66% |
| Gilead Sciences Inc | 3.34% | 3.54% |
| Boston Scientific Corp | 2.18% | 1.42% |
| Neurocrine Biosciences Inc | 1.41% | 1.57% |
Source: SEC Form N-PORT
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
DLHIX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
FAQ
What is the difference between ETHSX and DLHIX?
Which is cheaper, ETHSX or DLHIX?
Should I own both ETHSX and DLHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.